8. Huntington disease Clinical trials / Disease details
Clinical trials : 242 / Drugs : 205 - (DrugBank : 62) / Drug target genes : 85 - Drug target pathways : 159
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00980694 (ClinicalTrials.gov) | September 2009 | 17/9/2009 | Bioavailability of Ubiquinol in Huntington Disease | Bioavailability of Ubiquinol in Huntington Disease | Huntington Disease | Dietary Supplement: ubiquinol | University of Rochester | Kaneka Corporation | Completed | 18 Years | N/A | Both | 6 | Phase 1 | United States |